Colostrum-derived Peptides™ in Bovine Colostrum May Help in Fight Against Alzheimer’s Disease

Colostrum-derived Peptides™ in Bovine Colostrum May Help in Fight Against Alzheimer’s Disease

Colostrum-derived Peptides™ in Bovine Colostrum May Help in Fight Against Alzheimer's Disease

As a person grows older, he or she may become susceptible to memory loss, cognitive decline, and dementia. Recent research suggests that many “young” people in their 40s are exhibiting early symptoms of Alzheimer’s disease. This should be a wake-up call for everyone. Research also suggests that the proline-rich polypeptides in bovine colostrum (CDPs) may help in the fight against Alzheimer’s disease and other brain diseases that involve cognitive decline.

What Is Cognitive Decline? 

According to the Centers for Disease Control and Prevention (CDC), cognition involves the combination of intuition, judgment, language, memory, and the ability to learn.

Cognitive decline may occur if cognition is impaired. During a period of cognitive decline, an individual may struggle to complete everyday tasks and activities.

More than 16 million Americans are living with cognitive impairment, CDC reports. As members of the “Baby Boomer” generation pass the age of 65, the risk of cognitive impairment is expected to increase dramatically for the foreseeable future.

Forgetfulness is one of the most common signs of cognitive decline. If an individual is suffering from cognitive decline, it may become more difficult for him or her to learn new things or remember things they have done in the past.

Typically, forgetfulness is a mild symptom of cognitive decline, not a serious memory problem, CDC notes. On the other hand, dementia and Alzheimer’s disease are chronic health issues that may lead to long-term memory loss.

What Is Dementia? 

Dementia refers to multiple symptoms associated with memory decline which limit an individual’s ability to perform everyday life activities, Alzheimer’s Association states. It is commonly referred to as a “sensitivity” or “senile dementia,” despite the fact that serious mental decline is not a normal part of aging.

Common dementia symptoms include impairments in reasoning, judgment, communication, and language, and difficulty to focus or pay attention. Many dementia patients suffer from short-term memory loss and may struggle to remember appointments and names, prepare meals, or forget to take medications or where they’ve placed items.

Dementia symptoms are progressive; this means the symptoms start slowly and will get worse over time.

The World Health Organization (WHO) estimates 47 million people are currently living with dementia. WHO predicts this figure will rise to 75 million by 2030, and the number of dementia cases is expected to triple by 2050.

In most instances, dementia is overwhelming for individuals who have it and their families. There is a lack of dementia awareness in many countries, WHO states. This often leads to stigmatization and barriers to proper diagnosis and care for dementia patients, according to WHO.

What Is Alzheimer’s Disease? 

Alzheimer’s disease is the most common form of dementia and begins with mild memory loss, CDC indicates. It is believed to begin affecting the brain even before a person experiences memory loss and other cognitive impairments that accompany the disorder.

Alzheimer’s disease affects a portion of the brain associated with memory, language, and thought control and can make it exceedingly difficult for a person to complete everyday activities. Moreover, age and genetics are two of the most common risk factors linked to Alzheimer’s disease.

An individual’s risk of developing Alzheimer’s disease increases as he or she gets older. In fact, the National Institute on Aging points out the prevalence of Alzheimer’s disease doubles every five years for people 65 years of age and older.

The Alzheimer’s Foundation of America (AFA) estimates 5.1 million Americans suffer from Alzheimer’s disease. Meanwhile, some studies have predicted the number of Alzheimer’s disease patients in the United States will reach 88.5 million by 2050, or approximately 20 percent of the U.S. population.

How to Combat Cognitive Decline, Dementia, and Alzheimer’s Disease 

There is no cure for cognitive decline, but there are many ways that an individual can reduce the risk of cognitive decline.

NHS Choices points out eating a healthy diet, maintaining a healthy weight, and exercising regularly may reduce a person’s risk of dementia and other causes of cognitive decline.

Maintaining social interactions and learning new things (languages, hobbies, reading, solving puzzles, etc.) is helpful in keeping the mind active.

Furthermore, avoiding excess alcohol consumption, not smoking, and maintaining healthy blood pressure levels may deliver overall long-lasting health benefits and lower a person’s risk of cognitive decline.

The Impact of Colostrum on Cognitive Decline

Colostrum is secreted by female mammals in the initial days after giving birth. It contains a vast array of immune factors, of which proline-rich polypeptides are abundant. Colostrum-derived Peptides (CDPs) have been shown to:

  • Improve mood and cognition in humans
  • Increase the lifespan of cells
  • Limit brain cell deterioration and prevent mitochondrial dysfunction
  • Lower reactive oxygen species that can cause cellular damage and stress

CDPs also may help reduce or prevent the symptoms of Alzheimer’s disease, along with the symptoms of Huntington’s disease, sporadic ALS, epilepsy, post-stroke neurodegration, and other neurodegenerative disorders.

Additionally, colostrum contains immunoglobulins, antibodies, lactoferrin, and growth factors, to maintain gut and immune health.

The Bottom Line on Bovine Colostrum 

The National Center for Biotechnology Information reports a recent study was performed to evaluate the use of bovine colostrum on intracerebral hemorrhage-induced apoptotic neuronal cell death in rats. The study revealed colostrum supplementation helped improved short-term memory by suppressing hemorrhage-induced apoptotic neuronal cell death in the rat hippocampus. It indicated colostrum may benefit brain function after a hemorrhagic stroke by suppressing apoptotic cell death.

In a double-blind, placebo-controlled study, researchers at the University Medical School in Wroclaw, Poland found oral administration of CDPs isolated from colostrum improved the outcome of Alzheimer’s patients with mild to moderate dementia.

Bovine colostrum contains a plethora of immune-enhancing components, including CDPs that support RNA and DNA repair, stem cell initiation and differentiation, and identification of damaged or diseased cells (which can later be removed). Therefore, it’s very likely that bovine colostrum supplementation may play a crucial role in reducing the risk of cognitive decline, dementia, and Alzheimer’s disease in middle-age people or may delay the debilitating effects for those who are in the earliest stages of cognitive decline. Stay tuned as this is an area of significant interest, especially because at present, there are no truly effective pharmacological treatments for Alzheimer’s disease.

Powdered Colostum-LD® is certified to contain a minimum of 4.5-5% CDPs. Regular supplementation is necessary to maintain overall health and address some of the specific issues associated with aging, including muscle and bone loss. For additional benefit, Sovereign Laboratories recommends a concentrated oral CDP spray such as Colostrum-IC®.